Editorial mailbox.

What we read

Corrections to anything on the site — particularly anything in the References bibliography or anything cited as a quantitative claim. If a study has been retracted, a regulatory status has changed, a DOI is broken, or a published value has been revised in an erratum, send it along and the affected page will be updated with a note.

Pointers to recent peer-reviewed CJC-1295 literature that the editorial pass missed are welcome, particularly anything published in 2024-2025. Pointers to FDA briefing materials, WADA technical documents, or other regulatory primary sources are welcome. Editorial notes on the writing — clarity, factual ambiguity, missing context — are also welcome.

What we cannot help with

We cannot tell you where to obtain CJC-1295. We cannot recommend a vendor, a compounding pharmacy, a clinic, a protocol, or a dose. We cannot evaluate any specific product, batch, vial, or Certificate of Analysis. We cannot tell you whether any CJC-1295 use is legal in your jurisdiction. We cannot tell you whether any specific health condition would benefit from any GH-axis intervention.

We cannot answer questions about WADA compliance for your specific testing pool — that conversation belongs with your sport's anti-doping authority. We cannot answer medical questions about your health — those belong with a licensed clinician you see in person. We cannot tell you what your blood IGF-1 number means in any clinical sense.

The site is editorial only. The mailbox reflects that.

The form

A simple email form below. Subject line, message body, return email address. Submissions route to the editorial mailbox at editor@cjc1295get.com. No personal health information will be discussed or retained. No marketing list, no newsletter sign-up, no tracking pixel.

For anything urgent or anything involving a medical question, please contact a licensed clinician directly rather than this address.